We are live on ! Find out more
Emerald Advisers

Emerald Advisers Portfolio holdings

AUM $4.25B Turnover 24.28%
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.29%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Avg Time Held
2.5 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
LGN icon
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 23.28%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TTI icon
51
TETRA Technologies
TTI
$789M
$35M 0.82%
3,093,379
+431,852
+16% +$4.23M
2021 Q1
21 quarters
AMSC icon
52
American Superconductor
AMSC
$1.22B
$35M 0.82%
843,956
+86,552
+11% +$3.91M
2024 Q4
6 quarters
MC icon
53
Moelis & Co
MC
$4.04B
$34.8M 0.82%
531,883
-16,194
-3% -$1.06M
2016 Q4
38 quarters
KTOS icon
54
Kratos Defense & Security Solutions
KTOS
$7.26B
$34.8M 0.82%
697,181
-138,748
-17% -$8.39M
2016 Q4
38 quarters
OLLI icon
55
Ollie's Bargain Outlet
OLLI
$5.21B
$34.2M 0.8%
444,778
+97,653
+28% +$8.14M
2023 Q3
11 quarters
RMBS icon
56
Rambus
RMBS
$9.29B
$33.5M 0.79%
252,693
-240,543
-49% -$31.3M
2023 Q1
13 quarters
TRVI icon
57
Trevi Therapeutics
TRVI
$1.8B
$33.5M 0.79%
1,797,611
-41,955
-2% -$610K
2025 Q4
2 quarters
ONTO icon
58
Onto Innovation
ONTO
$9.8B
$33.2M 0.78%
87,619
-30,804
-26% -$8.72M
2025 Q2
4 quarters
IMAX icon
59
IMAX
IMAX
$2.93B
$33M 0.78%
827,965
-21,183
-2% -$812K
2025 Q3
3 quarters
TMDX icon
60
Transmedics
TMDX
$2.45B
$32.6M 0.77%
490,491
+147,700
+43% +$12.5M
2019 Q2
28 quarters
RXO icon
61
RXO
RXO
$4.74B
$32.4M 0.76%
1,174,517
+736,046
+168% +$16.3M
2023 Q2
12 quarters
PLMR icon
62
Palomar
PLMR
$3.73B
$31.4M 0.74%
248,267
-50,092
-17% -$5.9M
2019 Q3
27 quarters
AAOI icon
63
Applied Optoelectronics
AAOI
$5.73B
$31.3M 0.74%
211,574
-222,308
-51% -$36.1M
2024 Q1
9 quarters
BJRI icon
64
BJ's Restaurants
BJRI
$1.2B
$31.2M 0.73%
513,574
-17,425
-3% -$762K
2021 Q1
21 quarters
TBBK icon
65
The Bancorp
TBBK
$2.07B
$29.9M 0.7%
478,025
-13,315
-3% -$763K
2024 Q4
6 quarters
HNGE icon
66
Hinge Health
HNGE
$9B
$29.8M 0.7%
358,655
+79,765
+29% +$4.33M
2026 Q1
1 quarter
AVAV icon
67
AeroVironment
AVAV
$6.26B
$29.1M 0.69%
176,383
-3,491
-2% -$625K
2022 Q4
14 quarters
CVLT icon
68
Commault Systems
CVLT
$7.02B
$28.1M 0.66%
198,459
+1,318
+0.7% +$142K
2024 Q3
7 quarters
MTRN icon
69
Materion
MTRN
$4.61B
$27.6M 0.65%
+92,808
New +$19.4M
2026 Q2
0 quarters
QBTS icon
70
D-Wave Quantum Inc
QBTS
$4.43B
$27.5M 0.65%
1,147,775
+607,444
+112% +$13.3M
2025 Q2
4 quarters
ARLO icon
71
Arlo Technologies
ARLO
$1.4B
$27.3M 0.64%
2,021,645
+2,716
+0.1% +$36.8K
2024 Q2
8 quarters
NKTR icon
72
Nektar Therapeutics
NKTR
$1.27B
$27.2M 0.64%
390,158
-4,446
-1% -$325K
2025 Q3
3 quarters
CUBI icon
73
Customers Bancorp
CUBI
$2.86B
$26.5M 0.62%
334,660
-8,549
-2% -$647K
2025 Q3
3 quarters
AXSM icon
74
Axsome Therapeutics
AXSM
$7.6B
$25.5M 0.6%
104,237
-3,373
-3% -$731K
2025 Q2
4 quarters
BOBS icon
75
Bobs Discount Furniture
BOBS
$2.13B
$25.4M 0.6%
1,607,068
+262,018
+19% +$3.25M
2026 Q1
1 quarter

Similar funds

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.